Cargando…
Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events
BACKGROUND: Cardiovascular disease and its sequelae are major causes of global mortality, and better methods are needed to identify patients at risk for future cardiovascular events. Gene expression analysis can inform on the molecular underpinnings of risk factors for cardiovascular events. Smoking...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767057/ https://www.ncbi.nlm.nih.gov/pubmed/29329538 http://dx.doi.org/10.1186/s12920-017-0318-6 |
_version_ | 1783292471011180544 |
---|---|
author | Wingrove, James A. Fitch, Karen Rhees, Brian Rosenberg, Steven Voora, Deepak |
author_facet | Wingrove, James A. Fitch, Karen Rhees, Brian Rosenberg, Steven Voora, Deepak |
author_sort | Wingrove, James A. |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease and its sequelae are major causes of global mortality, and better methods are needed to identify patients at risk for future cardiovascular events. Gene expression analysis can inform on the molecular underpinnings of risk factors for cardiovascular events. Smoking and aspirin have known opposing effects on platelet reactivity and MACE, however their effects on each other and on MACE are not well described. METHODS: We measured peripheral blood gene expression levels of ITGA2B, which is upregulated by aspirin and correlates with platelet reactivity on aspirin, and a 5 gene validated smoking gene expression score (sGES) where higher expression correlates with smoking status, in participants from the previously reported PREDICT trial (NCT 00500617). The primary outcome was a composite of death, myocardial infarction, and stroke/TIA (MACE). We tested whether selected genes were associated with MACE risk using logistic regression. RESULTS: Gene expression levels were determined in 1581 subjects (50.5% female, mean age 60.66 +/−11.46, 18% self-reported smokers); 3.5% of subjects experienced MACE over 12 months follow-up. Elevated sGES and ITGA2B expression were each associated with MACE (odds ratios [OR] =1.16 [95% CI 1.10–1.31] and 1.42 [95% CI 1.00–1.97], respectively; p < 0.05). ITGA2B expression was inversely associated with self-reported smoking status and the sGES (p < 0.001). A logistic regression model combining sGES and ITGA2B showed better performance (AIC = 474.9) in classifying MACE subjects than either alone (AIC = 479.1, 478.2 respectively). CONCLUSION: Gene expression levels associated with smoking and aspirin are independently predictive of an increased risk of cardiovascular events. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12920-017-0318-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5767057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57670572018-01-17 Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events Wingrove, James A. Fitch, Karen Rhees, Brian Rosenberg, Steven Voora, Deepak BMC Med Genomics Research Article BACKGROUND: Cardiovascular disease and its sequelae are major causes of global mortality, and better methods are needed to identify patients at risk for future cardiovascular events. Gene expression analysis can inform on the molecular underpinnings of risk factors for cardiovascular events. Smoking and aspirin have known opposing effects on platelet reactivity and MACE, however their effects on each other and on MACE are not well described. METHODS: We measured peripheral blood gene expression levels of ITGA2B, which is upregulated by aspirin and correlates with platelet reactivity on aspirin, and a 5 gene validated smoking gene expression score (sGES) where higher expression correlates with smoking status, in participants from the previously reported PREDICT trial (NCT 00500617). The primary outcome was a composite of death, myocardial infarction, and stroke/TIA (MACE). We tested whether selected genes were associated with MACE risk using logistic regression. RESULTS: Gene expression levels were determined in 1581 subjects (50.5% female, mean age 60.66 +/−11.46, 18% self-reported smokers); 3.5% of subjects experienced MACE over 12 months follow-up. Elevated sGES and ITGA2B expression were each associated with MACE (odds ratios [OR] =1.16 [95% CI 1.10–1.31] and 1.42 [95% CI 1.00–1.97], respectively; p < 0.05). ITGA2B expression was inversely associated with self-reported smoking status and the sGES (p < 0.001). A logistic regression model combining sGES and ITGA2B showed better performance (AIC = 474.9) in classifying MACE subjects than either alone (AIC = 479.1, 478.2 respectively). CONCLUSION: Gene expression levels associated with smoking and aspirin are independently predictive of an increased risk of cardiovascular events. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12920-017-0318-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-12 /pmc/articles/PMC5767057/ /pubmed/29329538 http://dx.doi.org/10.1186/s12920-017-0318-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wingrove, James A. Fitch, Karen Rhees, Brian Rosenberg, Steven Voora, Deepak Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events |
title | Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events |
title_full | Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events |
title_fullStr | Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events |
title_full_unstemmed | Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events |
title_short | Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events |
title_sort | peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767057/ https://www.ncbi.nlm.nih.gov/pubmed/29329538 http://dx.doi.org/10.1186/s12920-017-0318-6 |
work_keys_str_mv | AT wingrovejamesa peripheralbloodgeneexpressionsignatureswhichreflectsmokingandaspirinexposureareassociatedwithcardiovascularevents AT fitchkaren peripheralbloodgeneexpressionsignatureswhichreflectsmokingandaspirinexposureareassociatedwithcardiovascularevents AT rheesbrian peripheralbloodgeneexpressionsignatureswhichreflectsmokingandaspirinexposureareassociatedwithcardiovascularevents AT rosenbergsteven peripheralbloodgeneexpressionsignatureswhichreflectsmokingandaspirinexposureareassociatedwithcardiovascularevents AT vooradeepak peripheralbloodgeneexpressionsignatureswhichreflectsmokingandaspirinexposureareassociatedwithcardiovascularevents |